Your Cheat Sheet to the top healthcare business news...
While Vivus launched its drug Qysmia at the end of September, ahead of rivals Arena and Orexigen, the race for the most successful treatment has not yet been won...
Your Cheat Sheet to the top healthcare business news...
Arena’s weight-loss pill Belviq became the first obesity drug approved by the Federal Drug Administration since Xenical in 1999...
Analysts Lee Kalowski of Credit Suisse believes the stock represents an attractive "risk-reward profile"...
Vivus was up more than 17 percent in early trading Wednesday after winning regulatory approval Tuesday for its drug Qsymia, widely considered to be the most effective in a new generation of anti-obesity pills...
Your Cheat Sheet to the top healthcare business news ...
It is the first obesity medication cleared for sale in the United States in 13 years...
Here's the top trending stocks of the day ...
Your Cheat Sheet to the top healthcare business news ...
Your Cheat Sheet to the top healthcare business news ...
Your Cheat Sheet to the top healthcare business news ...
Here's the top trending stocks of the day ...
These stocks are popping in late trading...
Manufacturing impressed Wall Street, earnings impressed investors, and Oil is as hot as Egypt ...